Nitsch‐Osuch 2010.
Study characteristics | |||
Patient sampling | Cross‐sectional study
Prospective design
Sample: unclear
Direct comparison of different RADTs: no
Direct comparison of several throat culture techniques: no
Person performing the throat sample: unclear Exclusion if recent antibiotics use before inclusion: yes Clinical selection of patients: explicit criteria but not a score (see below) Presenting signs and symptoms: fever > 38°C and sore throat, no cough and sneezing Age range for inclusion: 2 to 15 years |
||
Patient characteristics and setting | Sample size: 188
Age (distribution): mean (SD) = 5.5 (2.6) years GAS prevalence according to culture (with 95% confidence interval): 33.5% (95% CI not reported) Country of study: Poland Sex (% of girls): 48% Clinical severity assessment: none Clinical setting: unclear Single‐ or multi‐centre study: unclear |
||
Index tests | Throat swab (1 single, 1 double, 2 different): not reported Commercial name of the RADT: Test Strep A (SureScreen) Type of RADT: EIA |
||
Target condition and reference standard(s) | Throat culture medium: not reported Atmosphere of incubation: not reported Duration of incubation: not reported GAS confirmation: not reported Number of plates inoculated: not reported Assessment of GAS antibody response: no Relevant details: throat culture technique not described | ||
Flow and timing | No follow‐up | ||
Comparative | |||
Type of study | Conference abstract | ||
Notes | — | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was it a cross‐sectional study or a RCT? | Yes | ||
Were selection criteria clearly described (at least presenting signs and symptoms and age limits for inclusion)? | Yes | ||
Was clinical selection of patients avoided? | No | ||
Were patients seen in an ambulatory care setting? | Yes | ||
High | High | ||
DOMAIN 2: Index Test All tests | |||
Were the RADT results interpreted with blinding of the results of culture? | Unclear | ||
Was the type of the RADT mentioned (EIA or OIA)? | Yes | ||
Were RADTs conducted during consultation time? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 3: Reference Standard | |||
Were culture results interpreted with blinding of the results of the RADT? | Unclear | ||
Is the throat culture method likely to correctly identify GAS (laboratory culture on a blood agar plate during 48 hr)? | Unclear | ||
Were the culture medium, atmosphere, duration of incubation and GAS‐confirmation technique described? | No | ||
High | High | ||
DOMAIN 4: Flow and Timing | |||
Was the delay between the performance of the RADT and throat culture plating less than 48 hours? | Unclear | ||
Did all patients receive a throat culture? | Yes | ||
Did patients receive the same throat culture method? | Yes | ||
Were undetermined/uninterpretable results reported? | No | ||
Were withdrawals from the study explained? | No | ||
Low |